keyword
MENU ▼
Read by QxMD icon Read
search

Gcmaf

keyword
https://www.readbyqxmd.com/read/29748462/the-effect-of-fucoidan-from-the-brown-alga-fucus-evanescence-on-the-activity-of-%C3%AE-n-acetylgalactosaminidase-of-human-colon-carcinoma-cells
#1
Irina Bakunina, Oksana Chadova, Olesya Malyarenko, Svetlana Ermakova
α- N -acetylgalactosaminidase (EC 3.2.1.49) (alpha-NaGalase) catalyzes the hydrolysis of N -acetamido-2-deoxy-α-d-galactoside residues from non-reducing ends of various complex carbohydrates and glycoconjugates. It is known that human cancer cells express an alpha-NaGalase, which accumulates in the blood plasma of patients. The enzyme deglycosylates the Gc protein-derived macrophage activating factor (GcMAF) and inhibits macrophage activity acting as an immunosuppressor. The high specific activity 0...
May 10, 2018: Marine Drugs
https://www.readbyqxmd.com/read/28782090/purified-umbilical-cord-derived-mesenchymal-stem-cell-treatment-in-a-case-of-systemic-lupus-erythematosus
#2
Christopher D Phillips, Pornpatcharin Wongsaisri, Thein Htut, Terry Grossman
INTRODUCTION: Systemic lupus erythematosus (SLE) is a multiple organ system autoimmune disorder for which there is no known cure. METHODS: We report a case of a young adult lady with SLE and Sjogren's with diagnostic and clinical resolution following purified umbilical cord derived mesenchymal stem cell (MSC) and globulin component protein macrophage activating factor (GcMAF) therapy in a combined multidisciplinary integrative medicine protocol. RESULTS: Our patient had complete reversal of all clinical and laboratory markers...
December 2017: Clinical and Translational Medicine
https://www.readbyqxmd.com/read/27515218/is-chondroitin-sulfate-responsible-for-the-biological-effects-attributed-to-the-gc-protein-derived-macrophage-activating-factor-gcmaf
#3
Marco Ruggiero, Heinz Reinwald, Stefania Pacini
We hypothesize that a plasma glycosaminoglycan, chondroitin sulfate, may be responsible for the biological and clinical effects attributed to the Gc protein-derived Macrophage Activating Factor (GcMAF), a protein that is extracted from human blood. Thus, Gc protein binds chondroitin sulfate on the cell surface and such an interaction may occur also in blood, colostrum and milk. This interpretation would solve the inconsistencies encountered in explaining the effects of GcMAF in vitro and in vivo. According to our model, the Gc protein or the GcMAF bind to chondroitin sulfate both on the cell surface and in bodily fluids, and the resulting multimolecular complexes, under the form of oligomers trigger a transmembrane signal or, alternatively, are internalized and convey the signal directly to the nucleus thus eliciting the diverse biological effects observed for both GcMAF and chondroitin sulfate...
September 2016: Medical Hypotheses
https://www.readbyqxmd.com/read/27503803/glycan-structure-of-gc-protein-derived-macrophage-activating-factor-as-revealed-by-mass-spectrometry
#4
Chad R Borges, Douglas S Rehder
Disagreement exists regarding the O-glycan structure attached to human vitamin D binding protein (DBP). Previously reported evidence indicated that the O-glycan of the Gc1S allele product is the linear core 1 NeuNAc-Gal-GalNAc-Thr trisaccharide. Here, glycan structural evidence is provided from glycan linkage analysis and over 30 serial glycosidase-digestion experiments which were followed by analysis of the intact protein by electrospray ionization mass spectrometry (ESI-MS). Results demonstrate that the O-glycan from the Gc1F protein is the same linear trisaccharide found on the Gc1S protein and that the hexose residue is galactose...
September 15, 2016: Archives of Biochemistry and Biophysics
https://www.readbyqxmd.com/read/27354653/case-report-gcmaf-treatment-in-a-patient-with-multiple-sclerosis
#5
Toshio Inui, Goro Katsuura, Kentaro Kubo, Daisuke Kuchiike, Leslye Chenery, Yoshihiro Uto, Takahito Nishikata, Martin Mette
BACKGROUND/AIM: Gc protein-derived macrophage-activating factor (GcMAF) has various functions as an immune modulator, such as macrophage activation, anti-angiogenic activity and anti-tumor activity. Clinical trials of second-generation GcMAF demonstrated remarkable clinical effects in several types of cancers. Thus, GcMAF-based immunotherapy has a wide application for use in the treatment of many diseases via macrophage activation that can be used as a supportive therapy. Multiple sclerosis (MS) is considered to be an autoimmune disorder that affects the myelinated axons in the central nervous system (CNS)...
July 2016: Anticancer Research
https://www.readbyqxmd.com/read/27354652/case-report-a-non-small-cell-lung-cancer-patient-treated-with-gcmaf-sonodynamic-therapy-and-tumor-treating-fields
#6
Toshio Inui, Haruka Amitani, Kentaro Kubo, Daisuke Kuchiike, Yoshihiro Uto, Takahito Nishikata, Martin Mette
BACKGROUND/AIM: Macrophage activating factor (MAF)-based immunotherapy has a wide application for use in treating many diseases via macrophage activation. Sonodynamic therapy (SDT) using low-intensity ultrasound and tumor treating field (TTF) therapy are novel therapeutic modalities. SDT is usually combined with ozone therapy to improve local hypoxia within the tumor environment. CASE REPORT: We treated a 77-year-old male diagnosed with non-small cell lung cancer ((NSCLC) stage 3B) using second-generation serum GcMAF and oral colostrum MAF-based immunotherapy combined with SDT, TTF and ozone therapies...
July 2016: Anticancer Research
https://www.readbyqxmd.com/read/27141354/small-cell-lung-cancer-recruitment-of-macrophages-by-circulating-tumor-cells
#7
Gerhard Hamilton, Barbara Rath, Lukas Klameth, Maximilan J Hochmair
Tumor-associated macrophages (TAMs) play an important role in tumor progression, suppression of antitumor immunity and dissemination. Blood monocytes infiltrate the tumor region and are primed by local microenvironmental conditions to promote tumor growth and invasion. Although many of the interacting cytokines and factors are known for the tumor-macrophage interactions, the putative contribution of circulating tumor cells (CTCs) is not known so far. These specialized cells are characterized by increased mobility, ability to degrade the extracellular matrix (ECM) and to enter the blood stream and generate secondary lesions which is a leading cause of death for the majority of tumor patients...
March 2016: Oncoimmunology
https://www.readbyqxmd.com/read/26168499/oral-colostrum-macrophage-activating-factor-for-serious-infection-and-chronic-fatigue-syndrome-three-case-reports
#8
Toshio Inui, Kentaro Kubo, Daisuke Kuchiike, Yoshihiro Uto, Takahito Nishikata, Norihiro Sakamoto, Martin Mette
BACKGROUND: Gc protein-derived macrophage-activating factor (GcMAF) immunotherapy has been steadily advancing over the last two decades. Oral colostrum macrophage-activating factor (MAF) produced from bovine colostrum has shown high macrophage phagocytic activity. GcMAF-based immunotherapy has a wide application for use in treating many diseases via macrophage activation or for use as supportive therapy. RESULTS: Three case studies demonstrate that oral colostrum MAF can be used for serious infection and chronic fatigue syndrome (CFS) without adverse effects...
August 2015: Anticancer Research
https://www.readbyqxmd.com/read/26168491/degalactosylated-desialylated-bovine-colostrum-induces-macrophage-phagocytic-activity-independently-of-inflammatory-cytokine-production
#9
Yoshihiro Uto, Tomohito Kawai, Toshihide Sasaki, Ken Hamada, Hisatsugu Yamada, Daisuke Kuchiike, Kentaro Kubo, Toshio Inui, Martin Mette, Ken Tokunaga, Akio Hayakawa, Akiteru Go, Tomohiro Oosaki
BACKGROUND/AIM: Colostrum contains antibodies, such as immunoglobulin G (IgG), immunoglobulin A (IgA) and immunoglobulin M (IgM), and, therefore, has potent immunomodulating activity. In particular, IgA has an O-linked sugar chain similar to that in the group-specific component (Gc) protein, a precursor of the Gc protein-derived macrophage-activating factor (GcMAF). In the present study, we investigated the macrophage-activating effects of degalactosylated/desialylated bovine colostrum...
August 2015: Anticancer Research
https://www.readbyqxmd.com/read/25782915/effects-of-oxaliplatin-and-oleic-acid-gc-protein-derived-macrophage-activating-factor-on-murine-and-human-microglia
#10
Jacopo J V Branca, Gabriele Morucci, Francesca Malentacchi, Stefania Gelmini, Marco Ruggiero, Stefania Pacini
The biological properties and characteristics of microglia in rodents have been widely described, but little is known about these features in human microglia. Several murine microglial cell lines are used to investigate neurodegenerative and neuroinflammatory conditions; however, the extrapolation of the results to human conditions is frequently met with criticism because of the possibility of species-specific differences. This study compares the effects of oxaliplatin and of oleic acid Gc-protein-derived macrophage-activating factor (OA-GcMAF) on two microglial cell lines, murine BV-2 cells and human C13NJ cells...
September 2015: Journal of Neuroscience Research
https://www.readbyqxmd.com/read/25304987/gc-protein-derived-macrophage-activating-factor-counteracts-the-neuronal-damage-induced-by-oxaliplatin
#11
Gabriele Morucci, Jacopo J V Branca, Massimo Gulisano, Marco Ruggiero, Ferdinando Paternostro, Alessandra Pacini, Lorenzo Di Cesare Mannelli, Stefania Pacini
Oxaliplatin-based regimens are effective in metastasized advanced cancers. However, a major limitation to their widespread use is represented by neurotoxicity that leads to peripheral neuropathy. In this study we evaluated the roles of a proven immunotherapeutic agent [Gc-protein-derived macrophage activating factor (GcMAF)] in preventing or decreasing oxaliplatin-induced neuronal damage and in modulating microglia activation following oxaliplatin-induced damage. The effects of oxaliplatin and of a commercially available formula of GcMAF [oleic acid-GcMAF (OA-GcMAF)] were studied in human neurons (SH-SY5Y cells) and in human microglial cells (C13NJ)...
February 2015: Anti-cancer Drugs
https://www.readbyqxmd.com/read/25297451/retraction-note-to-immunotherapy-of-metastatic-colorectal-cancer-with-vitamin-d-binding-protein-derived-macrophage-activating-factor-gcmaf
#12
(no author information available yet)
No abstract text is available yet for this article.
December 2014: Cancer Immunology, Immunotherapy: CII
https://www.readbyqxmd.com/read/25180398/-immunotherapy-of-metastatic-breast-cancer-patients-with-vitamin-d-binding-protein-derived-macrophage-activating-factor-gcmaf-by-yamamoto-n-suyama-h-yamamoto-n-and-ushijima-n
#13
(no author information available yet)
No abstract text is available yet for this article.
September 15, 2014: International Journal of Cancer. Journal International du Cancer
https://www.readbyqxmd.com/read/25075104/case-report-a-breast-cancer-patient-treated-with-gcmaf-sonodynamic-therapy-and-hormone-therapy
#14
Toshio Inui, Kaori Makita, Hirona Miura, Akiko Matsuda, Daisuke Kuchiike, Kentaro Kubo, Martin Mette, Yoshihiro Uto, Takahito Nishikata, Hitoshi Hori, Norihiro Sakamoto
Gc protein-derived macrophage-activating factor (GcMAF) occurs naturally in the human body. It has various functions, such as macrophage activation and antitumor activities. Recently, immunotherapy has become an attractive new strategy in the treatment of cancer. GcMAF-based immunotherapy can be combined with many other therapies. Sonodynamic therapy (SDT) using low-intensity ultrasound is a novel therapeutic modality. Ultrasound has been demonstrated to activate a number of sonosensitive agents allowing for the possibility of non-invasive targeted treatment for both superficial and deep-seated tumors...
August 2014: Anticancer Research
https://www.readbyqxmd.com/read/25075102/a-novel-assay-system-for-macrophage-activating-factor-activity-using-a-human-u937-cell-line
#15
Mami Ishikawa, Takahiro Inoue, Toshio Inui, Daisuke Kuchiike, Kentaro Kubo, Yoshihiro Uto, Takahito Nishikata
BACKGROUND: Macrophages play important roles in antitumor immunity, and immunotherapy with the group-specific component protein-derived macrophage-activating factor (GcMAF) has been reported to be effective in patients with various types of cancers. However, in macrophage research, it is important to properly evaluate macrophage activity. MATERIALS AND METHODS: U937 macrophages were induced by 12-O-tetradecanoyl-13-phorbolacetate (TPA). The phagocytic activity of macrophages was evaluated as the internalized beads ratio...
August 2014: Anticancer Research
https://www.readbyqxmd.com/read/24982371/oleic-acid-deglycosylated-vitamin-d-binding-protein-nitric-oxide-a-molecular-triad-made-lethal-to-cancer
#16
Marco Ruggiero, Emma Ward, Rodney Smith, Jacopo J V Branca, David Noakes, Gabriele Morucci, Margit Taubmann, Lynda Thyer, Stefania Pacini
BACKGROUND: Oleic Acid (OA) has been shown to have anticancer properties mediated by interaction with proteins such as α-lactalbumin and lactoferrins. Therefore, we synthesized complexes of OA and Gc protein-derived macrophage activating factor (GcMAF) that inhibits per se cancer cell proliferation and metastatic potential. We hypothesised that OA-GcMAF complexes could exploit the anticancer properties of both OA and GcMAF in a synergistic manner. We postulated that the stimulating effects of GcMAF on macrophages might lead to release of nitric oxide (NO)...
July 2014: Anticancer Research
https://www.readbyqxmd.com/read/24739187/the-in-vitro-gcmaf-effects-on-endocannabinoid-system-transcriptionomics-receptor-formation-and-cell-activity-of-autism-derived-macrophages
#17
Dario Siniscalco, James Jeffrey Bradstreet, Alessandra Cirillo, Nicola Antonucci
BACKGROUND: Immune system dysregulation is well-recognized in autism and thought to be part of the etiology of this disorder. The endocannabinoid system is a key regulator of the immune system via the cannabinoid receptor type 2 (CB2R) which is highly expressed on macrophages and microglial cells. We have previously published significant differences in peripheral blood mononuclear cell CB2R gene expression in the autism population. The use of the Gc protein-derived Macrophage Activating Factor (GcMAF), an endogenous glycosylated vitamin D binding protein responsible for macrophage cell activation has demonstrated positive effects in the treatment of autistic children...
April 17, 2014: Journal of Neuroinflammation
https://www.readbyqxmd.com/read/24179708/gc-protein-derived-macrophage-activating-factor-decreases-%C3%AE-n-acetylgalactosaminidase-levels-in-advanced-cancer-patients
#18
Lynda Thyer, Emma Ward, Rodney Smith, Jacopo Jv Branca, Gabriele Morucci, Massimo Gulisano, David Noakes, Robert Eslinger, Stefania Pacini
α-N-acetylgalactosaminidase (nagalase) accumulates in the serum of cancer patients and its activity correlates with tumor burden, aggressiveness and clinical disease progression. The administration of GC protein-derived macrophage-activating factor (GcMAF) to cancer patients with elevated levels of nagalase has been associated with a decrease of serum nagalase activity and with significant clinical benefits. Here, we report the results of the administration of GcMAF to a heterogeneous cohort of patients with histologically diverse, advanced neoplasms, generally considered as "incurable" diseases...
August 1, 2013: Oncoimmunology
https://www.readbyqxmd.com/read/23857228/a-novel-role-for-a-major-component-of-the-vitamin-d-axis-vitamin-d-binding-protein-derived-macrophage-activating-factor-induces-human-breast-cancer-cell-apoptosis-through-stimulation-of-macrophages
#19
Lynda Thyer, Emma Ward, Rodney Smith, Maria Giulia Fiore, Stefano Magherini, Jacopo J V Branca, Gabriele Morucci, Massimo Gulisano, Marco Ruggiero, Stefania Pacini
The role of vitamin D in maintaining health appears greater than originally thought, and the concept of the vitamin D axis underlines the complexity of the biological events controlled by biologically active vitamin D (1,25(OH)(2)D3), its two binding proteins that are the vitamin D receptor (VDR) and the vitamin D-binding protein-derived macrophage activating factor (GcMAF). In this study we demonstrate that GcMAF stimulates macrophages, which in turn attack human breast cancer cells, induce their apoptosis and eventually phagocytize them...
July 2013: Nutrients
https://www.readbyqxmd.com/read/23780980/clinical-experience-of-integrative-cancer-immunotherapy-with-gcmaf
#20
Toshio Inui, Daisuke Kuchiike, Kentaro Kubo, Martin Mette, Yoshihiro Uto, Hitoshi Hori, Norihiro Sakamoto
BACKGROUND: Immunotherapy has become an attractive new strategy in the treatment of cancer. The laboratory and clinical study of cancer immunotherapy is rapidly advancing. However, in the clinical setting, the results of cancer immunotherapy are mixed. We therefore contend that cancer immunotherapy should be customized to each patient individually based on their immune status and propose an integrative immunotherapy approach with second-generation group-specific component macrophage activating factor (GcMAF)-containing human serum...
July 2013: Anticancer Research
keyword
keyword
166904
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"